{
  "id": 1784884,
  "title": "GLP-1s and Birth Control; Retatrutide Lawsuits; Air Pollution and Menopause",
  "url": "https://urgent.news/2026/08/18/glp-1s-and-birth-control-retatrutide-lawsuits-air-pollution-and",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-18T18:49:17.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/endocrinology/generalendocrinology/122655"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Experts suggested that GLP-1 agonists may reduce the effectiveness of birth control pills. (The Hill) A phase III trial of avexitide, a first-in-class GLP-1 receptor antagonist, met its primary endpoint of reducing low blood...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}